Gordon Michael Adam has filed 5 insider transactions across 2 companies since May 2024.
Most recent transaction: a grant/award of 110000 shares of PAVmed Inc. ($PAVM) on April 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | PAVmed Inc. | $PAVM | Gordon Michael Adam | General Counsel | A | Common stock | 110000 | $0.00 | 115,000.0000 | 21,554,546 | 2200.00% | 0.51% |
| Feb. 20, 2026 | Lucid Diagnostics Inc. | $LUCD | Gordon Michael Adam | General Counsel and Secretary | A | Common stock | 300000 | $0.00 | 1,000,000.0000 | 137,683,002 | 42.86% | 0.22% |
| Sept. 30, 2025 | PAVmed Inc. | $PAVM | Gordon Michael Adam | General Counsel | A | Common Stock | 150000 | $0.00 | 150,000.0000 | 65,291,623 | 9999.99% | 0.23% |
| Feb. 20, 2025 | Lucid Diagnostics Inc. | $LUCD | Gordon Michael Adam | General Counsel and Secretary | A | Common stock | 300000 | $0.00 | 700,000.0000 | 66,969,390 | 75.00% | 0.45% |
| May 7, 2024 | Lucid Diagnostics Inc. | $LUCD | Gordon Michael Adam | General Counsel and Secretary | A | Common stock | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |